NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Luvme Hair, a leading brand in premium human hair lace front wigs and extensions, announces its 2025 Black Friday wigs sale alongside a comprehensive saving guide to assist consumers in planning purchases and evaluating deals. The guide outlines key dates, eligibility details, and practical budgeting tips, with objective recommendations across popular categories—including brown wig options and other colored hair wigs—aimed at helping shoppers secure value while ma ...

公司股息分配 - 公司宣布2025年11月每股派发0.08美元的月度股息 [1] - 股息将于2025年11月28日支付给普通股股东 [1] - 公司按月宣布股息 下一次股息预计在12月初宣布 [2] 股息税务特征与支付条件 - 本次股息中约20%预计为资本返还 [3] - 股息税务特征的最终确定需等待2025财年结束后 可能与当前预估有实质性差异 [3] - 未来股息支付需经公司董事会批准 并满足债务协议和优先股条款的约定 [2] 公司投资策略与业务 - 公司为在纽交所上市的非多元化封闭式管理投资公司 [4] - 投资目标为提供高税后总回报 重点向股东进行现金分配 [4] - 公司计划将至少80%的总资产投资于能源基础设施公司证券 [4] 股息政策说明 - 公司向普通股股东支付的现金股息比率可能不时调整 [5] - 股息金额不保证 可能因投资组合持仓和市场条件等多种因素而变化 [5]

ARS Pharma to showcase a late-breaking oral presentation and six poster presentations highlighting real world impact of neffy® (epinephrine nasal spray) Oral presentation reports about 9 out of every 10 patients experiencing anaphylaxis were effectively treated with a single dose of neffy Case reports detail real-world data and effective use of neffy in patients who experience anaphylaxis during oral food challenges or allergy immunotherapy SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, ...

Accessibility StatementSkip Navigation Next Phase of Partnership Supports Scalable Growth and Margin Improvement SINGAPORE, Nov. 3, 2025 /PRNewswire/ -- YY Group Holding Limited (NASDAQ: YYGH) ("YY Group" or the "Company"), a global leader in on-demand workforce solutions and integrated facilities management (IFM), building on the memorandum of understanding it signed in August 2025, today announced it has executed a formal partnership agreement with KEENON (Hong Kong) Limited ("KEENON Robotics" or "KEENON" ...

PALO ALTO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, announced today that ten moderated digital posters will be shared at the American Heart Association (AHA) Scientific Sessions 2025, taking place in New Orleans, LA from November 7 - 10, 2025. Moderated Digital Posters: Acoramidis Effect on All-Cause Mortality in Patients with p.V142I (V122I) Variant ATTR-CM: Findings f ...

Highly experienced biopharma financial officer joins leadership team CFO hire bolsters Kalaris’ leadership team and supports continued growth of the company as it enrolls its Phase 1b/2 study in treatment naïve nAMD patients PALO ALTO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Kalaris Therapeutics (“Kalaris”), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases, today announced the appointment of Matthew Gall, MBA, as Ch ...

Newark, NJ , Nov. 03, 2025 (GLOBE NEWSWIRE) -- : Genie Energy, Ltd. (NYSE: GNE), a leading retail energy and renewable energy solutions provider, today announced results for the third quarter of 2025. Michael Stein, Chief Executive Officer of Genie Energy, commented: "Genie Energy achieved another quarter of double-digit topline growth to attain record third quarter revenue. The revenue increase was fueled by an increase in per meter electricity consumption, rising commodity prices, and RCE base growth at ...

Significant Milestone to provide access to American ShareholdersTORONTO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Q-Gold Resources Ltd. (TSXV: QGR; OTCQB: QGLDF) (“QGold” or the “Company”) is pleased to announce that its common shares have commenced trading on the OTCQB® Venture Market, a U.S. trading platform operated by OTC Markets Group Inc. Effective October 28, 2025, QGold began trading under the symbol “QGLDF.” Investors can access real-time quotes and market information at https://www.otcmarkets.com/stock/ ...

FDA lifts clinical hold following review of Company’s Complete Response submission.Company expects to restart U.S. enrollment in late 2025 or early 2026 across 20 clinical sites.Early data suggests that LTI-03 may not only slow fibrosis but also promote lung healing. AUSTIN, Texas, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fi ...

公司战略与定位 - 公司宣布大幅扩展其比特币挖矿业务，总挖矿算力达到约11.3 EH/s，使其成为全球顶级的公开上市比特币矿商之一 [1][2] - 此次扩张是公司数字基础设施战略的一部分，旨在为下一代游戏和娱乐平台构建能力，将数字货币、人工智能、用户参与度和计算能力与传统游戏体验相融合 [1][3][5] - 公司定位为游戏娱乐公司中率先建立大规模加密和高性能计算基础设施的先锋 [1][5] 运营与财务影响 - 新增挖矿算力约8.19 EH/s，通过收购获得，交易对价为发行最多314,515,762股A类普通股，预计在2025年12月15日前完成 [4] - 运营预计每月产生约160枚比特币，将为公司创造显著的新收入来源，并强化其财务基础 [2] - 此次扩张与公司长期愿景及近期宣布的阿布扎比投资办公室合作伙伴关系相符，支持其在阿布扎比设立部门总部 [3] 管理层评论摘要 - 联合首席执行官Hicham Chahine表示，此举以快速推进数字基础设施战略，大规模计算能力为公司在游戏娱乐领域探索高性能计算、加密挖矿和AI应用提供了更强基础 [5] - 首席运营官Carl Agren表示，将高效精准地部署这些资产，立即实现稳定产出，并为未来的更高级应用做好准备 [5] - 近期的一系列交易加速了公司数字基础设施能力的建设，彰显了其对实现战略路线图和为股东及合作伙伴创造长期价值的承诺 [5] 公司背景 - NIP Group是一家全球性数字娱乐公司，通过战略性数字基础设施投资推动游戏和电子竞技的演进 [6] - 公司业务生态系统多元化，涵盖电竞战队、场馆与赛事、内容与网红网络、游戏发行、酒店及数字资产运营，触达数亿粉丝 [6] - 公司在欧洲、中东、亚洲和美洲运营，与领先的游戏公司合作以突破互动娱乐的界限 [6]